Literature DB >> 24706356

Domiciliary floseal prevents admission for epistaxis in hereditary hemorrhagic telangiectasia.

Laura Warner1, Jane Halliday, Karen James, John de Carpentier.   

Abstract

Entities:  

Keywords:  FloSeal; epistaxis; hereditary haemorrhagic telangiectasia

Mesh：

Substances：

Year:  2014        PMID： 24706356     DOI： 10.1002/lary.24701

Source DB:  PubMed          Journal:  Laryngoscope        ISSN： 0023-852X            Impact factor:   3.325


× No keyword cloud information.
  4 in total

1.  Evaluating the use of Floseal haemostatic matrix in the treatment of epistaxis: a prospective, control-matched longitudinal study.

Authors:  Andrew S Lau; Navdeep S Upile; Lepa Lazarova; Andrew C Swift
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-26       Impact factor: 2.503

2.  The use of FloSeal haemostatic sealant in the management of epistaxis: a prospective clinical study and literature review.

Authors:  O C Wakelam; P A Dimitriadis; J Stephens
Journal:  Ann R Coll Surg Engl       Date:  2016-08-04       Impact factor: 1.951

3.  Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT).

Authors:  John M Lee; Vincent Wu; Marie E Faughnan; Andrea Lasso; Andrea Figol; Shaun J Kilty
Journal:  J Otolaryngol Head Neck Surg       Date:  2019-10-15

4.  Osler-Weber-Rendu Disease Uncovered by Preeclampsia in a Case Report.

Authors:  Jamal Ouachaou; Hamza Mimouni; Mohammed Maarad; Yassine Mellagui; Asmae Oulad Amar; Houssam Bkiyar; Imane Kamaoui; Brahim Housni
Journal:  Case Rep Obstet Gynecol       Date:  2020-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.